GSK (GSK.L), opens new tab said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its best-selling shingles vaccine lowers the risk of ...
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
A new study found that shingles vaccination cut older adults ... recently reported some evidence that it does. Vaccine manufacturer GSK last month announced a collaboration with UK health ...